AI assistant
Sending…
InfuSystem Holdings, Inc — Director's Dealing 2021
May 21, 2021
33639_dirs_2021-05-21_5f6cd504-5199-461f-9003-b905c87e738f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InfuSystem Holdings, Inc (INFU)
CIK: 0001337013
Period of Report: 2021-05-18
Reporting Person: Dilorio Richard (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-18 | Stock Option (right to buy) | $19.5 | A | 20678 | Acquired | 2031-05-18 | Common Stock (20678) | Direct |
| 2021-05-18 | Restricted Stock Units | $ | A | 14103 | Acquired | Common Stock (14103) | Direct | |
| 2021-05-18 | Restricted Stock Units | $ | A | 2821 | Acquired | Common Stock (2821) | Direct |
Footnotes
F1: The option, representing the right to purchase a total of 20,678 shares of InfuSystem Holdings, Inc. common stock, vests in three equal annual installments beginning May 18, 2022.
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: These restricted stock units will cliff vest on May 18, 2024.
F4: These restricted stock units will cliff vest on May 18, 2022.
More from InfuSystem Holdings, Inc
Transaction in Own Shares
2026
May 18
Regulatory Filings
2026
May 18
Board/Management Information
2026
May 14
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 7
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 3
Investor Presentation
2026
Feb 27